Literature DB >> 2337276

Effects of furosemide on the racing times of Thoroughbreds.

C R Sweeney1, L R Soma, A D Maxson, J E Thompson, S J Holcombe, P A Spencer.   

Abstract

The effects of furosemide on the racing times of 79 horses without exercise-induced pulmonary hemorrhage (EIPH) and 52 horses with EIPH were investigated. Racing times were adjusted to 1-mile equivalent racing times by 2 speed handicapping methods, and analysis of covariance was used to adjust actual racing times by winning time and distance for each race. All 3 methods of determining racing time indicated that geldings without EIPH had significantly faster racing times (P less than 0.05) when given furosemide before racing than when furosemide was not given before racing. Females and colts without EIPH were determined to have faster racing times when furosemide was given before racing, but the difference was not significant. Geldings with EIPH had significantly faster racing times (P = 0.0231) when given furosemide before racing, as determined by one of the speed handicapping methods. There was a strong correlation (range 0.9314 to 0.9751) between the 1-mile equivalent racing times, as determined by the 2 speed handicapping methods for horses with and without EIPH. Furosemide failed to prevent the development of EIPH in many horses that were previously considered to be EIPH-negative. When given furosemide, 62 (25.3%) of 235 EIPH-negative horses were EIPH-positive after racing. Furosemide had questionable efficacy for prevention of EIPH in known EIPH-positive horses. Thirty-two (61.5%) of 52 EIPH-positive horses given furosemide before a race remained EIPH-positive after that race.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337276

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

Review 1.  A survey of the literature (1995-1999) on the kinetics of drugs in camels (Camelus dromedarius).

Authors:  A A Alquarawi; B H Ali
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

2.  Specificity and sensitivity of ultrasonography and endoscopy for the diagnosis of exercise-induced pulmonary haemorrhage (EIPH) in 157 race horses.

Authors:  F Ferrucci; G Stancari; E Zucca; S Ayalon; C Falcone; E Ferro
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

Review 3.  A review of the pathophysiology of exercise-induced pulmonary haemorrhage in the equine athlete.

Authors:  L L Donaldson
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

Review 4.  Exercise-induced pulmonary hemorrhage in a nonathlete: case report and review of physiology.

Authors:  Amit Diwakar; Gregory A Schmidt
Journal:  Lung       Date:  2014-02-17       Impact factor: 2.584

5.  Exercise induced pulmonary hemorrhage in horses: American College of Veterinary Internal Medicine consensus statement.

Authors:  K W Hinchcliff; L L Couetil; P K Knight; P S Morley; N E Robinson; C R Sweeney; E van Erck
Journal:  J Vet Intern Med       Date:  2015 May-Jun       Impact factor: 3.333

6.  Exercise-induced pulmonary hemorrhage in barrel racing horses in the Pacific Northwest region of the United States.

Authors:  Jenifer R Gold; Donald P Knowles; Todd Coffey; Warwick M Bayly
Journal:  J Vet Intern Med       Date:  2018-02-20       Impact factor: 3.333

Review 7.  Equine Welfare during Exercise: An Evaluation of Breathing, Breathlessness and Bridles.

Authors:  David J Mellor; Ngaio J Beausoleil
Journal:  Animals (Basel)       Date:  2017-05-26       Impact factor: 2.752

8.  Exercise-induced pulmonary hemorrhage: where are we now?

Authors:  David C Poole; Howard H Erickson
Journal:  Vet Med (Auckl)       Date:  2016-11-21

9.  Relationship between tracheobronchoscopic score and bronchoalveolar lavage red blood cell numbers in the diagnosis of exercise-induced pulmonary hemorrhage in horses.

Authors:  Carolina M Lopez Sanchez; Clark Kogan; Jenifer R Gold; Debra C Sellon; Warwick M Bayly
Journal:  J Vet Intern Med       Date:  2019-12-27       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.